For example, in the SURMOUNT-4 trial, tirzepatide discontinuers were randomized to a placebo, and they were unaware whether they were receiving tirzepatide or not. In real-world settings, the most common reasons for discontinuation are cost or insurance-related issues, and side effects, with the former predominating, he added
Identifying it as a secreted factor, they named it Glucagon or Glucose Agonist
Failing to report a medication could result in delays, denial of certification, certificate suspension or other enforcement actions
Some patients experience appetite suppression and weight loss on fluoxetine, particularly early in treatment, while others experience weight gain over longer periods of use, a pattern associated with many SSRIs